146 related articles for article (PubMed ID: 22174448)
1. Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8+ T cells via trogocytosis.
Gary R; Voelkl S; Palmisano R; Ullrich E; Bosch JJ; Mackensen A
J Immunol; 2012 Jan; 188(2):744-52. PubMed ID: 22174448
[TBL] [Abstract][Full Text] [Related]
2. Trogocytosis is a gateway to characterize functional diversity in melanoma-specific CD8+ T cell clones.
Uzana R; Eisenberg G; Sagi Y; Frankenburg S; Merims S; Amariglio N; Yefenof E; Peretz T; Machlenkin A; Lotem M
J Immunol; 2012 Jan; 188(2):632-40. PubMed ID: 22156347
[TBL] [Abstract][Full Text] [Related]
3. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
4. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
[TBL] [Abstract][Full Text] [Related]
5. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.
Latchman YE; Liang SC; Wu Y; Chernova T; Sobel RA; Klemm M; Kuchroo VK; Freeman GJ; Sharpe AH
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10691-6. PubMed ID: 15249675
[TBL] [Abstract][Full Text] [Related]
6. Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis.
Hudrisier D; Clemenceau B; Balor S; Daubeuf S; Magdeleine E; Daëron M; Bruhns P; Vié H
J Immunol; 2009 Nov; 183(10):6102-13. PubMed ID: 19841164
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells.
Ferlazzo G; Wesa A; Wei WZ; Galy A
J Immunol; 1999 Oct; 163(7):3597-604. PubMed ID: 10490952
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
Sim JH; Park MJ; Park S; Lee ES
Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
[TBL] [Abstract][Full Text] [Related]
9. Mature dendritic cells are superior to immature dendritic cells in expanding antigen-specific naive and memory CD8+ T cells.
Tomiyama M; Takahara M; Egawa K; Nieda M
Anticancer Res; 2004; 24(5C):3327-33. PubMed ID: 15515428
[TBL] [Abstract][Full Text] [Related]
10. Salmonella impairs CD8 T cell response through PD-1: PD-L axis.
López-Medina M; Carrillo-Martín I; Leyva-Rangel J; Alpuche-Aranda C; Ortiz-Navarrete V
Immunobiology; 2015 Dec; 220(12):1369-80. PubMed ID: 26210046
[TBL] [Abstract][Full Text] [Related]
11. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells.
Zarling AL; Johnson JG; Hoffman RW; Lee DR
J Immunol; 1999 May; 162(9):5197-204. PubMed ID: 10227993
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
[TBL] [Abstract][Full Text] [Related]
13. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.
Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P
Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
Song MY; Park SH; Nam HJ; Choi DH; Sung YC
J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
[TBL] [Abstract][Full Text] [Related]
15. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
[TBL] [Abstract][Full Text] [Related]
16. Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.
Kaiser AD; Schuster K; Gadiot J; Borkner L; Daebritz H; Schmitt C; Andreesen R; Blank C
Eur J Immunol; 2012 Mar; 42(3):662-71. PubMed ID: 22144176
[TBL] [Abstract][Full Text] [Related]
17. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells.
Riond J; Elhmouzi J; Hudrisier D; Gairin JE
Scand J Immunol; 2007 Oct; 66(4):441-50. PubMed ID: 17850589
[TBL] [Abstract][Full Text] [Related]
18. Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cells.
Yamahira A; Narita M; Nakamura T; Watanabe N; Kaji M; Taniguchi T; Hashimoto S; Furukawa T; Toba K; Aizawa Y; Kuzushima K; Takahashi M
Leuk Res; 2011 Jun; 35(6):793-9. PubMed ID: 21216464
[TBL] [Abstract][Full Text] [Related]
19. siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions.
Iwamura K; Kato T; Miyahara Y; Naota H; Mineno J; Ikeda H; Shiku H
Gene Ther; 2012 Oct; 19(10):959-66. PubMed ID: 22113316
[TBL] [Abstract][Full Text] [Related]
20. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
Chen W; Ford MS; Young KJ; Zhang L
Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
